| abstract |
An active agent useful for preventing or treating the onset of Staphylococcus aureus infection, particularly MRSA infection, and a therapeutic composition containing the active agent are provided. A therapeutically effective amount of a LukA polypeptide having a specific amino acid sequence (LukA), a LukB polypeptide having a specific amino acid sequence (LukB), and a therapeutically effective amount of an anti-LukA antibody that specifically binds to LukA Or an active agent useful for preventing or treating the development of S. aureus infection, comprising at least one of a therapeutically effective amount of an antibody that specifically binds to LukB, and containing the active agent Therapeutic composition. [Selection diagram] None |